antares

This autoinjector will be approved by the end of 2017 in the U.S. The double-blind, multicenter Subcutaneous Testosterone Efficacy and Safety in Adult Men Diagnosed with Hypogonadism (STEADY) trial of a novel, pre-filled auto injector enrolled 150 hypogonadal adult men with two baseline...